Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography

Amino Acids

Volumn 29, Issue 4 SPEC. ISS., 2005, Pages 415-428

  Gester, S ^a   Wuest, F ^a   Pawelke, B ^a   Bergmann, R ^a   Pietzsch, J ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

18F Fluorobenzaldehyde; Horner Wadsworth Emmons reaction; Polyphenols; Positron emission tomography (PET); Resveratrol

Indexed keywords

3,5 DIHYDROXY 4' FLUOROSTILBENE F 18; FLUORINE 18; POLYPHENOL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; FLUORINE; RESVERATROL; STILBENE DERIVATIVE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOACCUMULATION; CAMERA; CONFERENCE PAPER; DRUG SYNTHESIS; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORNER WADSWORTH EMMONS REACTION; IMAGING; IN VIVO STUDY; ISOTOPE LABELING; MALE; METABOLISM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHEMISTRY; RAT; SEPARATION TECHNIQUE; ANIMAL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; SYNTHESIS; TUMOR CELL LINE; WISTAR RAT;

ANIMALIA; RATTUS NORVEGICUS; VITACEAE;

ANIMALS; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; HUMANS; MALE; MODELS, ANIMAL; MOLECULAR STRUCTURE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; STILBENES; TUMOR CELLS, CULTURED;

EID: 29144480171     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-005-0205-x     Document Type: Conference Paper

References (60)

1. W Andlauer J Kolb K Siebert P Furst 2000 Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp Clin Res 26 47 55
2. L Bavaresco C Fregoni E Cantu M Trevisan 1999 Stilbene compounds: from the grapevine to wine. Drugs Exp Clin Res 25 57 63
3. R Bergmann R Helling C Heichert M Scheunemann P Maeding H Wittrisch B Johannsen T Henle 2001 Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N epsilon-carboxymethyllysine (CML) and N epsilon-carboxyethyllysine (CEL). Food 45 182 188
4. 11C-labelled alkenes via a Heck coupling reaction. J Chem Soc Perkin Trans 1 2000 3031 3034
5. P Brito LM Almeida TC Dinis 2002 The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. Free Radic Res 36 621 631
6. DI Cho NY Koo WJ Chung TS Kim SY Ryu SY Im KM Kim 2002 Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci 71 2071 2082
7. C De Santi A Pietrabissa R Spisni F Mosca GM Pacifici 2000a Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30 609 617
8. C De Santi A Pietrabissa F Mosca GM Pacifici 2000b Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30 1047 1054
9. L Fremont 2000 Biological effects of resveratrol. Life Sci 66 663 673
10. J Germain P Deslongchamps 2002 Total synthesis of (±)-Momilactone A. J Org Chem 67 5269 5278
11. J Gerold U Holzenkamp H Meier 2001 Bis-, Tris-, and Tetrakis (squaraines) linked by stilbenoid scaffolds. Eur J Org Chem 14 2757 2763
12. AJ Gescher WP Steward 2003 Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12 953 957
13. V Granados-Soto 2003 Pleiotropic effects of resveratrol. Drug News Perspect 16 299 307
14. J Gusman H Malonne G Atassi 2001 A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22 1111 1117
15. UG Haider D Sorescu KK Griendling AM Vollmar VM Dirsch 2003 Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol 63 925 932
16. R Hain B Bieseler H Kindl G Schroder R Stocker 1990 Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol 15 325 335
17. HD Hao LR He 2004 Mechanisms of cardiovascular protection by resveratrol. J Med Food 7 290 298
18. MS Jang EN Cai GO Udeani KV Slowing CF Thomas CWW Beecher HHS Fong NR Farnsworth AD Kinghorn RG Mehta RC Moon JM Pezzuto 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218 220
19. B Jannin M Menzel J-P Berlot D Delmas A Lançon N Latruffe 2004 Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 68 1113 1118
20. ME Juan J Buenafuente I Casals JM Planas 2002 Plasmatic levels of trans-resveratrol in rats. Food Res Int 35 195 199
21. MI Kaldas UK Walle T Walle 2003 Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 55 307 312
22. 11C]styrene. J Labelled Compd Radiopharm 28 1115 1120
23. YA Kim SH Rhee KY Park YH Choi 2003 Antiproliferative effect of resveratrol in human prostate carcinoma cells. J Med Food 6 273 280
24. Y Kimura 2003 Pharmacological studies on resveratrol. Methods Find Exp Clin Pharmacol 25 297 310
25. AD Kinghorn BN Su DS Jang LC Chang D Lee JQ Gu EJ Carcache-Blanco AD Pawlus SK Lee EJ Park M Cuendet JJ Gills K Bhat HS Park E Mata-Greenwood LL Song M Jang JM Pezzuto 2004 Natural inhibitors of carcinogenesis. Planta Med 70 691 705
26. P Kopp 1998 Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138 619 620
27. G Kuhnle JP Spencer G Chowrimootoo H Schroeter ES Debnam SK Srai C Rice-Evans U Hahn 2000 Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272 212 217
28. JK Kundu YJ Surh 2004 Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 555 65 80
29. Y Li YG Shin C Yu JW Kosmeder WH Hirschelman JM Pezzuto RB van Breemen 2003 Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb Chem High Throughput Screen 6 757 767
30. 18F chemistry. In: Johannsen B, Seifert S (eds) Institute of Bioinorganic and Radiopharmaceutical Chemistry: Annual Report 2001 (FZR-340). Research Center Rossendorf, Dresden, p 58
31. H Meier U Dullweber 1997 Extension of the squaraine chromophore in symmetrical bis(stilbenyl)squaraines. J Org Chem 62 4821 4826
32. X Meng P Maliakal H Lu MJ Lee CS Yang 2004 Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 52 935 942
33. E Middleton Jr C Kandaswami TC Theoharides 2000 The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 673 751
34. NJ Miller CA Rice-Evans 1995 Antioxidant activity of resveratrol in red wine. Clin Chem 41 1789
35. H Morita H Noguchi J Schröder I Abe 2001 Novel polyketides synthesized with a higher plant stilbene synthase. Eur J Biochem 268 3759 3766
36. BK Park NR Kitteringham PM O'Neill 2001 Metabolism of fluorine-containing drugs. Annu Rev Pharmacol Toxicol 41 443 470
37. B Pawelke 2005 Metabolite analysis in positron emission tomography studies: examples from food sciences. Amino Acids 29 377 388
38. GR Pettit MP Grealish MK Jung E Hamel RK Pettit JC Chapuis JM Schmidt 2002 Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. J Med Chem 45 2534 2542
39. 18F] GBR 12936 via a Wittig reaction for use in the dopamine reuptake site study. J Labelled Compd Radiopharm 32 253 254
40. J Pietzsch R Bergmann F Wuest 2003 Flavonoide - Wirkmechanismen und neue Anwendungsmöglichkeiten (Teil 2). Bioforum 26 384 385
41. J Pietzsch R Bergmann F Wuest B Pawelke C Hultsch J van den Hoff 2005 Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies. Amino Acids 29 389 404
42. B Piver M Fer X Vitrac JM Merillon Y Dreano F Berthou D Lucas 2004 Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68 773 782
43. C Poetzsch B Beuthien-Baumann J van den Hoff 2003 Teilautomatisierte Segmentierung zur Quantifizierung von Metastasen bei der FDG-PET. Nuklearmedizin 42 26
44. E Pozo-Guisado MJ Lorenzo-Benayas PM Fernandez-Salguero 2004 Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109 167 173
45. 18F]fluoroestradiol-3,17β-disulphamate. Appl Radiat Isot 55 631 639
46. GJ Soleas EP Diamandis DM Goldberg 1997 Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11 287 313
47. SJ Slater JL Seiz AC Cook BA Stagliano CJ Buzas 2003 Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 1637 59 69
48. WC Still M Kahn A Mitra 1978 Rapid chromatographic technique for preparative separation with moderate resolution. J Org Chem 43 2923 2925
49. WY Sun Q Zong RL Gu BC Pan 1998 Synthesis of ardisinol II. Synthesis 11 1619 1622
50. SH Tsai SY Lin-Shiau JK Lin 1999 Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 126 673 680
51. M Varache-Lembège PW Teguo T Richard JP Monti G Deffieux J Vercauteren JM Mérillon A Nuhrich 2000 Structure-activity relationships of polyhydroxystilbene derivatives extracted from Vitis vinifera cell cultures as inhibitors of human platelet aggregation. Med Chem Res 10 253 267
52. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72 2219 2233
53. T Walle 2004 Absorption and metabolism of flavonoids. Free Radic Biol Med 36 829 837
54. T Walle F Hsieh MH DeLegge JE Oatis UK Walle 2004 High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32 1377 1382
55. 18F]fluorodexetimides. J Labelled Compd Radiopharm 28 1189 1199
56. JM Wu ZR Wang TC Hsieh JL Bruder JG Zou YZ Huang 2001 Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8 3 17
57. F Wuest 2005 Aspects of positron emission tomography radiochemistry as relevant for food chemistry. Amino Acids 29 323 339
58. 18F-labelling agent. Radiochim Acta 92 349 353
59. C Yu YG Shin A Chow Y Li JW Kosmeder YS Lee WH Hirschelman JM Pezzuto RG Mehta RB van Breemen 2002 Human, rat, and mouse metabolism of resveratrol. Pharm Res 19 1907 1914
60. L Yu ZJ Sun SL Wu CE Pan 2003 Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 9 2341 2343